These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 386428)
21. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B; Fischer C; Reimann I; Weimer KE; Beck G; Frölich JC Artery; 1980; 8(1):18-22. PubMed ID: 7000039 [TBL] [Abstract][Full Text] [Related]
22. Estimated rate of prostacyclin secretion into the circulation of normal man. FitzGerald GA; Brash AR; Falardeau P; Oates JA J Clin Invest; 1981 Nov; 68(5):1272-6. PubMed ID: 7028786 [TBL] [Abstract][Full Text] [Related]
23. Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. Falardeau P; Robillard M; Martineau A Prostaglandins; 1985 Apr; 29(4):621-8. PubMed ID: 3890022 [TBL] [Abstract][Full Text] [Related]
24. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma. Siess W; Dray F J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588 [TBL] [Abstract][Full Text] [Related]
25. PGI2 synthesis and excretion in dog kidney: evidence for renal PG compartmentalization. Boyd RM; Nasjletti A; Heerdt PM; Baer PG Am J Physiol; 1986 Jan; 250(1 Pt 2):F58-65. PubMed ID: 3079968 [TBL] [Abstract][Full Text] [Related]
26. Metabolism of prostacyclin in rat. Sun FF; Taylor BM Biochemistry; 1978 Sep; 17(19):4096-101. PubMed ID: 361075 [TBL] [Abstract][Full Text] [Related]
27. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion. Ylikorkala D; Viinikka L Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068 [TBL] [Abstract][Full Text] [Related]
28. Influence of 15-keto-metabolites and 13,14-dihydro-15-keto-metabolites of PGE2 and PGF2 alpha as well as of 6-keto-PGF1 alpha as a metabolite of PGI2 on aconitine induced cardiac arrhythmia in rats. Mest HJ; Förster W Acta Biol Med Ger; 1982; 41(9):819-22. PubMed ID: 6762025 [TBL] [Abstract][Full Text] [Related]
29. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132 [TBL] [Abstract][Full Text] [Related]
30. Metabolism of two PGF2 alpha analogues in primates: 15(S)-15-methyl-delta 4-cis-PGF1 alpha and 16,16-dimethyl-delta 4-cis-PGF1 alpha. Hansson G Prostaglandins; 1979 Nov; 18(5):745-71. PubMed ID: 120559 [TBL] [Abstract][Full Text] [Related]
31. [Establishment of microanalysis of prostaglandin metabolites by GC/MS and its clinical application]. Mizugaki M Yakugaku Zasshi; 1999 Jan; 119(1):61-80. PubMed ID: 9922710 [TBL] [Abstract][Full Text] [Related]
32. Release of prostaglandins by the mesenteric artery of the renovascular and spontaneously hypertensive rat. Desjardins-Giasson S; Gutkowska J; Garcia R; Genest J Can J Physiol Pharmacol; 1984 Jan; 62(1):89-93. PubMed ID: 6546893 [TBL] [Abstract][Full Text] [Related]
33. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases. Jarabak J; Fried J Prostaglandins; 1979 Aug; 18(2):241-6. PubMed ID: 42948 [TBL] [Abstract][Full Text] [Related]
34. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects. Quilley CP; McGiff JC; Lee WH; Sun FF; Wong PY Hypertension; 1980; 2(4):524-8. PubMed ID: 6995292 [TBL] [Abstract][Full Text] [Related]
35. Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation. Hawkings HJ; Smith JB; Nicolaou KC; Eling TE Prostaglandins; 1978 Dec; 16(6):871-84. PubMed ID: 219443 [TBL] [Abstract][Full Text] [Related]
36. Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs. Salmon JA; Mullane KM; Dusting GJ; Moncada S; Vane JR J Pharm Pharmacol; 1979 Aug; 31(8):529-32. PubMed ID: 39993 [TBL] [Abstract][Full Text] [Related]
37. In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Darimont C; Vassaux G; Gaillard D; Ailhaud G; Négrel R Int J Obes Relat Metab Disord; 1994 Dec; 18(12):783-8. PubMed ID: 7894515 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced release of prostaglandins: mechanisms and sources of production in coronary resistance vessels of the isolated rabbit heart. Nakhostine N; Laurent CE; Nadeau R; Cardinal R; Lamontagne D Can J Physiol Pharmacol; 1995 Dec; 73(12):1742-9. PubMed ID: 8834488 [TBL] [Abstract][Full Text] [Related]
39. The effect of clinical prostacyclin infusions in advanced arterial disease on platelet function and plasma 6-keto PGF1 alpha levels. Machin SJ; Chamone DA; Defreyn G; Vermylen J Br J Haematol; 1981 Mar; 47(3):413-22. PubMed ID: 7006673 [TBL] [Abstract][Full Text] [Related]
40. Formation of 6-keto prostaglandin E1 in mammalian kidneys. Griffiths RJ; Moore PK Br J Pharmacol; 1983 May; 79(1):149-55. PubMed ID: 6347300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]